Literature DB >> 21249714

Comparison of protocols and registry entries to published reports for randomised controlled trials.

Kerry Dwan1, Douglas G Altman, Lynne Cresswell, Michaela Blundell, Carrol L Gamble, Paula R Williamson.   

Abstract

BACKGROUND: Publication of complete trial results is essential if people are to be able to make well-informed decisions about health care. Selective reporting of randomised controlled trials (RCTs) is a common problem.
OBJECTIVES: To systematically review studies of cohorts of RCTs to compare the content of trial reports with the information contained in their protocols, or entries in a trial registry. SEARCH STRATEGY: We conducted electronic searches in Ovid MEDLINE (1950 to August 2010); Ovid EMBASE (1980 to August 2010); ISI Web of Science (1900 to August 2010) and the Cochrane Methodology Register (Issue 3, 2010), checked reference lists, and asked authors of eligible studies to identify further studies. Studies were not excluded based on language of publication or our assessment of their quality. SELECTION CRITERIA: Published or unpublished cohort studies comparing the content of protocols or trial registry entries with published trial reports. DATA COLLECTION AND ANALYSIS: Data were extracted by two authors independently. Risk of bias in the cohort studies was assessed in relation to follow up and selective reporting of outcomes. Results are presented separately for the comparison of published reports to protocols and trial registry entries. MAIN
RESULTS: We included 16 studies assessing a median of 54 RCTs (range: 2 to 362). Twelve studies compared protocols to published reports and four compared trial registry entries to published reports. In two studies, eligibility criteria differed between the protocol and publication in 19% and 100% RCTs. In one study, 16% (9/58) of the reports included the same sample size calculation as the protocol. In one study, 6% (4/63) of protocol-report pairs gave conflicting information regarding the method of allocation concealment, and 67% (49/73) of blinded studies reported discrepant information on who was blinded. In one study unacknowledged discrepancies were found for methods of handling protocol deviations (44%; 19/43), missing data (80%; 39/49), primary outcome analyses (60%; 25/42) and adjusted analyses (82%; 23/28). One study found that of 13 protocols specifying subgroup analyses, 12 of these 13 trials reported only some, or none, of these. Two studies found that statistically significant outcomes had a higher odds of being fully reported compared to nonsignificant outcomes (range of odds ratios: 2.4 to 4.7). Across the studies, at least one primary outcome was changed, introduced, or omitted in 4-50% of trial reports. AUTHORS'
CONCLUSIONS: Discrepancies between protocols or trial registry entries and trial reports were common, although reasons for these were not discussed in the reports. Full transparency will be possible only when protocols are made publicly available or the quality and extent of information included in trial registries is improved, and trialists explain substantial changes in their reports.

Entities:  

Mesh:

Year:  2011        PMID: 21249714      PMCID: PMC7390503          DOI: 10.1002/14651858.MR000031.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  66 in total

1.  Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies.

Authors:  S Hahn; P R Williamson; J L Hutton; P Garner; E V Flynn
Journal:  Stat Med       Date:  2000-12-30       Impact factor: 2.373

2.  Investigation of within-study selective reporting in clinical research: follow-up of applications submitted to a local research ethics committee.

Authors:  S Hahn; P R Williamson; J L Hutton
Journal:  J Eval Clin Pract       Date:  2002-08       Impact factor: 2.431

3.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

4.  Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.

Authors:  An-Wen Chan; Karmela Krleza-Jerić; Isabelle Schmid; Douglas G Altman
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

5.  Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee.

Authors:  Erik von Elm; Alexandra Röllin; Anette Blümle; Karin Huwiler; Mark Witschi; Matthias Egger
Journal:  Swiss Med Wkly       Date:  2008-04-05       Impact factor: 2.193

6.  Publication bias: evidence of delayed publication in a cohort study of clinical research projects.

Authors:  J M Stern; R J Simes
Journal:  BMJ       Date:  1997-09-13

7.  Publication bias and clinical trials.

Authors:  K Dickersin; S Chan; T C Chalmers; H S Sacks; H Smith
Journal:  Control Clin Trials       Date:  1987-12

8.  Publication bias: the case for an international registry of clinical trials.

Authors:  R J Simes
Journal:  J Clin Oncol       Date:  1986-10       Impact factor: 44.544

9.  Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory.

Authors:  Asbjørn Hróbjartsson; Julie Pildal; An-Wen Chan; Mette T Haahr; Douglas G Altman; Peter C Gøtzsche
Journal:  J Clin Epidemiol       Date:  2009-09       Impact factor: 6.437

10.  Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.

Authors:  Kristin Rising; Peter Bacchetti; Lisa Bero
Journal:  PLoS Med       Date:  2008-11-25       Impact factor: 11.069

View more
  99 in total

Review 1.  The contribution of systematic reviews to the practice of pediatric nephrology.

Authors:  Elisabeth Hodson; Jonathan C Craig
Journal:  Pediatr Nephrol       Date:  2012-04-04       Impact factor: 3.714

2.  [Trial registration for the improvement of transparency in scientific research. The German Association of Urology now enables registration in the register network of the WHO].

Authors:  F Kunath; C Becker; S Jena; J J Meerpohl; G Antes; B Wullich
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

Review 3.  From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.

Authors:  Kanwal Pratap Singh Raghav; Sminil Mahajan; James C Yao; Brian P Hobbs; Donald A Berry; Rebecca D Pentz; Alda Tam; Waun K Hong; Lee M Ellis; James Abbruzzese; Michael J Overman
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 4.  The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency.

Authors:  Claudia Pansieri; Chiara Pandolfini; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2015-08-05       Impact factor: 2.953

5.  Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations.

Authors:  Lin Wang; Benjamin Rouse; Arielle Marks-Anglin; Rui Duan; Qiyuan Shi; Kevin Quach; Yong Chen; Christopher Cameron; Christopher H Schmid; Tianjing Li
Journal:  J Clin Epidemiol       Date:  2019-06-18       Impact factor: 6.437

6.  [Postdoctoral qualification regulations of medical faculties in German universities. A comparison of 1998 and 2010].

Authors:  K Knobloch; H Sorg; P M Vogt
Journal:  Chirurg       Date:  2012-05       Impact factor: 0.955

7.  Evaluation of Journal Registration Policies and Prospective Registration of Randomized Clinical Trials of Nonregulated Health Care Interventions.

Authors:  Marleine Azar; Kira E Riehm; Nazanin Saadat; Tatiana Sanchez; Matthew Chiovitti; Lin Qi; Danielle B Rice; Brooke Levis; Claire Fedoruk; Alexander W Levis; Lorie A Kloda; Jonathan Kimmelman; Andrea Benedetti; Brett D Thombs
Journal:  JAMA Intern Med       Date:  2019-05-01       Impact factor: 21.873

8.  Standardizing data exchange for clinical research protocols and case report forms: An assessment of the suitability of the Clinical Data Interchange Standards Consortium (CDISC) Operational Data Model (ODM).

Authors:  Vojtech Huser; Chandan Sastry; Matthew Breymaier; Asma Idriss; James J Cimino
Journal:  J Biomed Inform       Date:  2015-07-15       Impact factor: 6.317

9.  SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krle A-Jerić; Asbjørn Hrobjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Dore; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Rev Panam Salud Publica       Date:  2015-12

10.  Redactions in protocols for drug trials: what industry sponsors concealed.

Authors:  Mikkel Marquardsen; Michelle Ogden; Peter C Gøtzsche
Journal:  J R Soc Med       Date:  2018-01-25       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.